Russells Mills | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	anxiety disorder, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2026-10-06		NCT07065240
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis	neurotrophic keratopathy	Recruiting	Phase 2	2026-09-25		NCT07568730
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2026-08-03		NCT06547489
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough	Refractory or Unexplained Chronic Cough	Active, not recruiting	Phase 2	2026-06-11		NCT06504446
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD	Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Active, not recruiting	Phase 3	2026-05-18		NCT06709014
LIFE-BTK Randomized Controlled Trial	Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder	Active, not recruiting	Not applicable	2025-12-30		NCT04227899